Remote Cardiac Stimulation for Ischemic Tissue Protection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current technologies fail to effectively protect the heart from injuries associated with cardiac ischemic events, such as myocardial infarction, by not adequately addressing tissue damage caused by ischemia.

Innovation Solution

A stimulation system that delivers cardioprotective stimulation to sites remote from the ischemic region, using an implantable medical device with a cardioprotective stimulation module and controller, which initiates alternating stimulation and non-stimulation periods to elicit a protective effect against cardiac ischemia without causing myocardial contraction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If direct stimulation is applied to the ischemic region, then tissue protection may be achieved, but it causes myocardial contraction which is harmful during ischemia

Engineering Contradiction:
Improvetissue protection effectivenessVSAvoidmyocardial contraction during ischemia
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses an intermediary approach by delivering stimulation to a remote non-ischemic region rather than directly to the ischemic myocardium. This remote conditioning acts as a mediator that triggers protective physiological responses (such as release of protective factors or activation of protective pathways) that then protect the ischemic tissue without causing direct harmful contraction in the affected area.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent segments the treatment approach by separating the stimulation site from the target protective site. The stimulation is applied to a distinct remote region (segment 1) while the protection is conferred on the ischemic region (segment 2), allowing independent optimization of each site's function without the harmful interactions that would occur with direct stimulation.

Inventive Principle:
Principle #1Segmentation

2Ease of manufacture

If conventional ischemia treatment is used, then standard care is provided, but it fails to adequately protect tissue from ischemic damage

Engineering Contradiction:
Improvetreatment implementation simplicityVSAvoidtissue protection effectiveness
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent implements preliminary action by delivering conditioning stimulation before the actual ischemic event occurs or at the very onset of ischemia. This pre-conditioning of the tissue through remote stimulation activates protective mechanisms in advance, making the tissue more resistant to the upcoming ischemic insult and improving protection effectiveness compared to conventional reactive treatments.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS8874207B2Method and apparatus for tissue protection against ischemia using remote conditioning
Publication Date: 2014.10.28 CARDIAC PACEMAKERS INC
  • US8874207B2 patent drawing
  • US8874207B2 patent drawing
  • US8874207B2 patent drawing

AI summary

A stimulation system delivers stimulation to protect an ischemic region of a body from tissue damage caused by ischemia. The stimulation is delivered to one or more stimulation sites remote from the ischemic region to elicit a physiological effect that protects the ischemic region from the tissue damage caused by ischemia. In one embodiment, the stimulation system delivers cardioprotective stimulation to one or more stimulation sites remote from the heart to protect the heart from injuries associated with cardiac ischemic events. In another embodiment, the stimulation system delivers remote conditioning stimulation to one or more stimulation sites in or on the heart to protect a non-cardiac region from injuries associated with non-cardiac ischemic events.